Free Trial

LivaNova (LIVN) Competitors

LivaNova logo
$35.07 +0.27 (+0.78%)
As of 04:00 PM Eastern

LIVN vs. STVN, GKOS, NARI, INSP, BLCO, SLNO, IRTC, PRCT, NVST, and TMDX

Should you be buying LivaNova stock or one of its competitors? The main competitors of LivaNova include Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), Inspire Medical Systems (INSP), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), PROCEPT BioRobotics (PRCT), Envista (NVST), and TransMedics Group (TMDX). These companies are all part of the "medical equipment" industry.

LivaNova vs.

LivaNova (NASDAQ:LIVN) and Stevanato Group (NYSE:STVN) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, community ranking, institutional ownership, analyst recommendations, risk, profitability and earnings.

Stevanato Group has lower revenue, but higher earnings than LivaNova. LivaNova is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LivaNova$1.25B1.52$17.55M$1.1430.66
Stevanato Group$1.10B6.02$157.62M$0.4845.75

In the previous week, LivaNova had 10 more articles in the media than Stevanato Group. MarketBeat recorded 16 mentions for LivaNova and 6 mentions for Stevanato Group. LivaNova's average media sentiment score of 1.28 beat Stevanato Group's score of 1.22 indicating that LivaNova is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LivaNova
10 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive
Stevanato Group
5 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

LivaNova received 375 more outperform votes than Stevanato Group when rated by MarketBeat users. Likewise, 69.71% of users gave LivaNova an outperform vote while only 62.50% of users gave Stevanato Group an outperform vote.

CompanyUnderperformOutperform
LivaNovaOutperform Votes
405
69.71%
Underperform Votes
176
30.29%
Stevanato GroupOutperform Votes
30
62.50%
Underperform Votes
18
37.50%

97.6% of LivaNova shares are owned by institutional investors. 0.3% of LivaNova shares are owned by insiders. Comparatively, 0.7% of Stevanato Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Stevanato Group has a net margin of 10.47% compared to LivaNova's net margin of 1.91%. LivaNova's return on equity of 13.81% beat Stevanato Group's return on equity.

Company Net Margins Return on Equity Return on Assets
LivaNova1.91% 13.81% 7.07%
Stevanato Group 10.47%9.86%5.79%

LivaNova currently has a consensus price target of $61.17, suggesting a potential upside of 75.01%. Given LivaNova's stronger consensus rating and higher possible upside, analysts clearly believe LivaNova is more favorable than Stevanato Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LivaNova
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.88
Stevanato Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71

LivaNova has a beta of 0.9, meaning that its stock price is 10% less volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.52, meaning that its stock price is 48% less volatile than the S&P 500.

Summary

LivaNova beats Stevanato Group on 14 of the 18 factors compared between the two stocks.

Remove Ads
Get LivaNova News Delivered to You Automatically

Sign up to receive the latest news and ratings for LIVN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LIVN vs. The Competition

MetricLivaNovaElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$1.90B$3.10B$5.30B$7.36B
Dividend YieldN/A1.80%5.11%4.32%
P/E Ratio83.2114.6621.6917.67
Price / Sales1.5243.57371.5292.57
Price / Cash11.1544.0938.1534.64
Price / Book1.473.256.373.94
Net Income$17.55M$94.03M$3.20B$247.37M
7 Day Performance-2.16%-3.83%1.91%0.64%
1 Month Performance-10.93%-9.82%-9.32%-6.98%
1 Year Performance-34.28%-22.53%9.64%-0.32%

LivaNova Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LIVN
LivaNova
3.5606 of 5 stars
$35.07
+0.8%
$61.17
+74.4%
-34.8%$1.91B$1.25B83.502,900Positive News
STVN
Stevanato Group
1.7327 of 5 stars
€19.23
+1.1%
N/A-23.5%$5.82B$1.10B40.914,650Positive News
GKOS
Glaukos
4.5562 of 5 stars
$85.87
+2.7%
$163.25
+90.1%
-2.4%$4.86B$383.48M-29.92780Analyst Forecast
News Coverage
High Trading Volume
NARI
Inari Medical
0.3435 of 5 stars
$79.97
flat
$68.00
-15.0%
N/A$4.68B$493.63M-59.24800
INSP
Inspire Medical Systems
4.6416 of 5 stars
$149.72
+5.5%
$226.70
+51.4%
-34.3%$4.46B$802.80M86.541,246Analyst Forecast
News Coverage
Positive News
Gap Up
BLCO
Bausch + Lomb
3.8736 of 5 stars
$11.86
-2.1%
$18.82
+58.7%
-16.5%$4.18B$4.79B-13.0312,500Gap Up
SLNO
Soleno Therapeutics
4.7799 of 5 stars
$69.64
+3.2%
$99.63
+43.1%
+82.4%$3.19BN/A-20.9830Analyst Forecast
Positive News
High Trading Volume
IRTC
iRhythm Technologies
1.0195 of 5 stars
$100.17
-0.2%
$119.73
+19.5%
-8.0%$3.15B$591.84M-27.521,790Positive News
PRCT
PROCEPT BioRobotics
2.3921 of 5 stars
$50.83
-0.8%
$94.29
+85.5%
+4.6%$2.79B$224.50M-26.07430Positive News
High Trading Volume
NVST
Envista
4.3739 of 5 stars
$15.27
-1.4%
$20.18
+32.2%
-21.0%$2.63B$2.51B-2.3512,700Analyst Forecast
Analyst Revision
News Coverage
TMDX
TransMedics Group
2.751 of 5 stars
$69.15
+2.2%
$122.70
+77.4%
-5.1%$2.33B$441.54M73.56210
Remove Ads

Related Companies and Tools


This page (NASDAQ:LIVN) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners